Tens of thousands of U.S. patients are starting treatments like Ozempic and Wegovy, but there aren't enough specialists to provide long-term support. Prescribing errors are a concern.
GLP-1 agonist drugs are becoming more accessible online, with various types of physicians prescribing them. However, regular monitoring is crucial due to potential side effects and varying effectiveness.
Improper use of weight-loss drugs due to lack of trained clinicians can lead to health risks and hinder insurance coverage. Guidance on dosage, side effects, diet, and exercise is crucial for patient outcomes.
[
Collection
]
[
|
...
]